Some assbag in Texas AG Paxton’s office hasn’t responded to my offer
To provide key info in their lawsuit against Pfizer
So here it is. YOU, dear reader, can send it to Paxton’s office. Find an email address that looks productive and get busy.
Paxton’s lawsuit focuses on the ineffectiveness of the Pfizer COVID vaccine.
I proved that case a long time ago.
I’ve posted the key article several times.
The New York Times, in an op-ed, originally made the case. I took off from the op-ed and explained exactly how Pfizer sank its own ship, and why.
In my email to Paxton’s office, I stated I’d need to speak with a person familiar with both the lawsuit and with clinical trials of vaccines. After that conversation, I would send the evidence.
Nothing came back.
Who’s pulling down a paycheck over there for being an idiot?
All right, here we go. Here’s the real Pfizer story:
Peter Doshi, associate editor of the medical journal BMJ, and Eric Topol, Scripps Research professor of molecular medicine, have written a devastating NY Times opinion piece about the ongoing COVID vaccine clinical trials.
They expose the fatal flaw in the large Pfizer, AstraZeneca, and Moderna trials.
September 22, 2020, the Times: “These Coronavirus Trials Don’t Answer the One Question We Need to Know” (here):
If you were to approve a coronavirus vaccine, would you approve one that you only knew protected people only from the most mild form of Covid-19, or one that would prevent its serious complications?
The answer is obvious. You would want to protect against the worst cases.
But that’s not how the companies testing three of the leading coronavirus vaccine candidates, Moderna, Pfizer and AstraZeneca, whose U.S. trial is on hold, are approaching the problem.
According to the protocols for their studies, which they released late last week, a vaccine could meet the companies’ benchmark for success if it lowered the risk of mild Covid-19, but was never shown to reduce moderate or severe forms of the disease, or the risk of hospitalization, admissions to the intensive care unit or death.
THE CLINICAL TRIALS WERE NOT DESIGNED TO SHOW THE VACCINE COULD PREVENT SERIOUS ILLNESS. OR HOSPITALIZATION. OR DEATH.
To say a vaccine works should mean that most people no longer run the risk of getting seriously sick. That’s not what these trials will determine.
This means these clinical trials are dead in the water.
And I could stop this article right here and walk away. Done. Finished. Nothing more need be said.
And you the reader could walk away. OK, done. The clinical trials of the vaccine were never intended to prevent serious illness of any kind. Never intended to prevent hospitalizations or deaths. End of story.
Goodbye. Forget the vaccine. Why would anyone want to take it?
But if you want to know WHY the clinical trials were designed this way, and HOW the con was played, and why it was actually necessary to design the clinical trials to be useless, read on.
Again, make sure you understand the clinical trials of the RNA vaccines were only designed to show effectiveness in preventing “mild cases of COVID,” (cough, fever, chills).
THERE IS NO NEED FOR A VACCINE THAT PREVENTS THOSE CASES.
Now let’s go deeper. Read the next section from the Times piece, and then I’ll make comments.
The Moderna and AstraZeneca studies will involve about 30,000 participants each; Pfizer’s will have 44,000. Half the participants will receive two doses of vaccines separated by three or four weeks, and the other half will receive saltwater placebo shots. The final determination of efficacy will occur after 150 to 160 participants develop Covid-19…
Now pay close attention. Here’s how it works. The vaccine companies are looking for a total of 150 mild COVID cases to occur, combined, in the two groups—those receiving the placebo and those receiving the vaccine. How would that happen? The researchers believe “the coronavirus is spreading everywhere” and it will pounce on some of the volunteers during the clinical trial.
Let’s say that, during the trial, 100 people receiving the placebo develop mild COVID-19 (cough, chills, fever), and only 50 people receiving the vaccine develop mild COVID.
The vaccine companies would say, “We just proved the vaccine is 50% effective in preventing COVID, and that’s all we need to do, in order to win emergency authorization from the FDA. Release the vaccine. Inject the world.”
The outcomes for ONLY 150 people equal “let’s shoot up seven billion people.”
And again, how is a COVID case defined? The authors of the Times piece have the answer:
In the Moderna and Pfizer trials, even a mild case of Covid-19—for instance, a cough plus a positive lab test—would qualify and muddy the results. AstraZeneca is slightly more stringent but would still count mild symptoms like a cough plus fever as a case.
“So, Doctor, the magic number is 150 ‘who cares’ mild cases? That’s the number that will decide the immediate fate of the planet?”
“And these 150 people, who you say develop mild COVID-19…no vaccine is needed.”
“And come to think of it, the people receiving the vaccine in the clinical trials could develop symptoms indistinguishable from mild COVID-19, as a result of the effects of the vaccine.”
“Yes, that’s right.”
“But you’re very confident in the success of the vaccine.”
“I have to be confident. If we’re exposed as incompetent frauds, our bottom line will take a huge hit. And we’ll wind up in prison.”
PART TWO: THE DEVIOUS TRICK
Now I’m going to go over the vital information again, but this time I’m going to show you how…
The vaccine companies can use the fatal flaws in their protocol design to…
Actually win approval of their COVID vaccine.
Stick with me. This is big.
Only 150 people are needed to make the major clinical trials of a COVID vaccine look like a success.
Out of 30,000 volunteers in a trial, researchers are waiting for 150 people to “come down with COVID-19.” MILD cases. They assume this will happen because they believe the coronavirus is everywhere, and it’ll infect some of their volunteers.
The researchers are waiting for a total of 150 people to “catch a mild case of COVID.” When that number is reached, everything stops.
Now comes the big moment. How many of those 150 mild COVID cases occurred in the group that received the vaccine, and how many in the group that received the placebo shot of salt water?
Let’s say only 50 mild COVID cases occurred in the vaccine group, and 100 in the placebo group. The researchers pop champagne corks. They say, “Look, the vaccine is 50% effective at preventing COVID, and that’s all we need to win emergency authorization from the FDA.”
BUT suppose 75 cases occurred in the vaccine group and 75 in the placebo group? No good. No good at all. No way to call the vaccine effective.
Now comes the “reshaping of the data.”
HERE WE GO.
The researchers say, “Wait. Thirty of the COVID cases in the vaccine group were REALLY just adverse reactions to the vaccine. They weren’t cases of COVID. You see, the vaccine can cause symptoms that are indistinguishable from mild COVID. Cough, fever, chills. ACTUALLY, there were only 30 cases of COVID in the vaccine group. There were 75 in the placebo group. That’s good enough. The vaccine IS effective. We’re golden. We can get emergency authorization from the FDA right now to shoot up everybody.”
Vaccine manufacturers HAVE KNOWN ALL ALONG that they could pull this trick.
Why leave things to chance?
Why risk a few hundred billion dollars of profit on a random distribution of mild COVID cases among the volunteers in their clinical trials?
The definition of a mild COVID case is EXACTLY what the vaccine manufacturers needed. It enabled them to hatch a plan, to make sure they didn’t fail.
They could pawn off a MILD case of COVID as a reaction to the vaccine. They could fake that without causing ripples. The FDA would say, “The vaccine reactions aren’t serious. All right, no problem. We’ll approve this vaccine for emergency use.”
However…If the manufacturers designed their clinical trial protocol to prevent serious cases of COVID—very serious pneumonia—then first of all, they would be waiting to see 150 cases of really sick people to occur among the volunteers.
That might never happen. In 100 years.
And second, if it did happen, and the manufacturers had to pull their devious switcheroo trick and blame the vaccine for some of these SERIOUS cases…
They would have to tell the FDA that their vaccine was causing life-threatening pneumonia; and the FDA, under a lot of scrutiny these days, would find it very difficult to overlook that.
FDA: “We can’t approve this vaccine. It could cause millions of cases of dire pneumonia…”
In gearing the protocol of the clinical trials to prevent MILD COVID cases, the manufacturers found a way to win FDA emergency authorization for their vaccine:
The manufacturers could pawn off mild COVID cases as “harmless vaccine reactions.”
These companies have no intention of failing, starting over, and spending a year recruiting 30,000 new volunteers. They want success and money now. They want to win the race.
And they will win, if the truth isn’t known and shared widely.
Every “expert,” in August 2021, is instructed to say the vaccine is definitely protecting people against severe illness and hospitalization. This is their promotional message to the world.
“Yes, even if you’re vaccinated, you could become infected with the virus, you could develop COVID, and you could pass the virus to other people, BUT you must take the shot. It will protect you from becoming severely ill.”
As you can see from what I’ve written above, this is a straight-out lie.
It was always a fantastic lie, from the beginning of COVID vaccine development, because the design of the clinical trials had nothing to do with preventing serious illness.
The clinical trials proved nothing.
The vaccine, in scientific terms, was worthless.
It was designed that way.
-- Jon Rappoport
Episode 56 of Rappoport Podcasts—“How ‘the virus’ became the biggest lie and the biggest cover story in the world”—is now posted on my substack. It’s a blockbuster. To listen, go here. To learn more about this episode of Rappoport Podcasts, go here.